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http:WHAT THIS PAPER ADDS
We report in this paper that inhibition of connexin channels (gap junctions and hemichannels) with the connexin
mimetic peptide, Gap27, strongly reduces cell death in human femoral arteries and saphenous veins when
present during cryopreservation/thawing. We further found that veins have a better conserved intimal layer
compared to arteries and have less cell death in the endothelial cells (ECs), making them the preparation of
choice when an intact endothelium is necessary. The present work brings up a novel and unexpected role for
connexin channels as a target to improve the viability of human blood vessels after cryopreservation.Objectives: Cryopreserved blood vessels are being increasingly employed in vascular reconstruction procedures
but freezing/thawing is associated with signiﬁcant cell death that may lead to graft failure. Vascular cells express
connexin proteins that form gap junction channels and hemichannels. Gap junction channels directly connect the
cytoplasm of adjacent cells and may facilitate the passage of cell death messengers leading to bystander cell
death. Two hemichannels form a gap junction channel but these channels are also present as free non-connected
hemichannels. Hemichannels are normally closed but may open under stressful conditions and thereby promote
cell death. We here investigated whether blocking gap junctions and hemichannels could prevent cell death after
cryopreservation.
Materials and methods: Inclusion of Gap27, a connexin channel inhibitory peptide, during cryopreservation and
thawing of human saphenous veins and femoral arteries was evaluated by terminal deoxynucleotidyl transferase
dUTP nick end labelling (TUNEL) assays and histological examination.
Results: We report that Gap27 signiﬁcantly reduces cell death in human femoral arteries and saphenous veins
when present during cryopreservation/thawing. In particular, smooth muscle cell death was reduced by 73% in
arteries and 71% in veins, while endothelial cell death was reduced by 32% in arteries and 51% in veins.
Conclusions: We conclude that inhibiting connexin channels during cryopreservation strongly promotes vascular
cell viability.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2012.12.012which could lead to late graft failure.1 The risk for throm-
bosis is enhanced by rejection, leading to loss of endothelial
lining and function, and in a later phase, by immune-related
intimal hyperplasia and ﬁbrosis.2 Even with the introduction
of immunosuppressive treatment, the improvement of
harvesting techniques and preservation ﬂuids and the use
of anticoagulation therapy the patency of these allografts
was not improved in most studies.3
The performance of cryopreserved vascular grafts is
suboptimal, mainly because of spontaneous vessel-wall
fractures4 appearing at the time of thawing or grafting.
Another important issue is that the current methods of
vascular cryopreservation used in most vascular banks lead
M. Bol et al. 383to a certain degree of loss of the intimal endothelial layer.5
Before arterial or venous grafts are implanted to bypass
occluded coronary arteries, they undergo extensive
apoptotic and necrotic cell death in the intimal and medial
layers.6 Cell death plays an important role in vascular graft
failure, and important for the present study, cellecell
communication may act to expand the cell death process to
neighbouring healthy cells, leading to bystander cell death
during cryopreservation and thawing.7
The most direct form of cellecell communication is
provided by gap junctions that consist of intercellular
channels composed of connexin proteins, named according
to their predicted molecular weight.8 Vascular cells abun-
dantly express connexins, with Cx37, Cx40 and Cx43 as the
most representative isoforms.9 Gap junction channels are
formed by the interaction of two hemichannels, belonging
to the membranes of adjacent cells and directly connect the
cytoplasm of neighbouring cells (Fig. 1). Gap junctions are
able to pass cell death messengers leading to bystander cell
death.7 Recent work from our group has demonstrated that
the physiological messenger inositol trisphosphate (IP3),
which can pass through gap junction channels, becomes
a crucial cell death-communicating messenger under pro-
apoptotic conditions.10 Additionally, hemichannels, which
are half gap junction channels, may by themselves promote
cell death. Unapposed hemichannels in the plasma
membrane are typically closed and only open when they
become incorporated into a gap junction. However, unap-
posed hemichannels not assembled into gap junctions mayFigure 1. Diagram of a bloodvessel illustrating the hypothesis
investigated in this paper. Vascular cells express connexins that
form gap junctions and hemichannels. Gap junctions connect the
cytoplasm of smooth muscle cells (SMCs) and of endothelial cells
(ECs); they also connect ECs with SMCs (Myo-endothelial gap
junctions). Gap junctions can communicate cell death from dying
to healthy neighbouring cells, resulting in bystander cell death.
Hemichannels are normally closed but may open in response to
mechanical strain, ischemia, inﬂammation, low extracellular
calcium, depolarization and altered phosphorylation or redox
status. This can lead to the loss of essential metabolites and ionic
shifts over the plasma membrane, thereby promoting cell death.
Gap27 inhibits hemichannels within minutes and gap junctions
with some delay; when present for several hours, both gap junc-
tions and hemichannels will be inhibited. We investigated whether
inclusion of Gap27 in the media used for cryopreservation and
thawing could protect against vascular cell death.open under certain conditions such as cell depolarisation,
decreased extracellular calcium, changes in intracellular
calcium concentration, alterations in phosphorylation or
redox status, mechanical strain and ischaemic and inﬂam-
matory conditions.11 Hemichannels are non-selective
channels that allow, like gap junctions, the passage of up to
1.5 kDa molecules; as a consequence, uncontrolled hemi-
channel opening may lead to cell death, caused by excessive
entry of sodium and calcium ion and loss of cellular aden-
osine triphosphate (ATP) or other crucial metabolic
molecules.12,13
Gap junction channels and hemichannels can be inhibited
by connexin mimetic peptides such as Gap26 and Gap27.14e
16 These peptides mimic a sequence on the extracellular
loops of the connexin protein and ﬁrst inhibit unapposed
hemichannels that have their extracellular loops freely
available for peptide interactions, followed by a somewhat
delayed inhibition of gap junctions.13,14,17 Previous work has
demonstrated that connexin mimetic peptides prevent the
propagation of cell death by inhibiting both gap junctions
and (unapposed) hemichannels.13 Recent work from others
has furthermore shown that these peptides can signiﬁcantly
improve the outcome after experimental ischaemia applied
to the heart or brain.18,19
Here, we used Gap27, which targets the two vascular
connexins Cx37 and Cx43,9 to investigate the hypothesis
that the combined inhibition of gap junctions and hemi-
channels exerts a cell-protective effect during the exposure
of donor blood vessels to the stressful events of cryopres-
ervation and thawing (Fig. 1). Our results show that Gap27
signiﬁcantly reduces cell death in endothelial cells (ECs) and
smooth muscle cells (SMCs) of cryopreserved human blood
vessels. The strongest effects of Gap27 were found in SMCs
of both vessel types and in the ECs in the veins. We further
found that veins have a better conserved intimal layer
compared to arteries and have less cell death in the ECs.
MATERIALS AND METHODS
Tissue preparation
Tissue samples of human femoral artery and saphenous
vein were obtained from deceased donors (age: 45  1.7
years, n ¼ 13) according to a protocol that was approved by
the ethical committee of the University Hospital Ghent.
Blood vessels were selected and procured according to the
Belgian law and guidelines of the Superior Health Council
Belgium. Exclusion criteria were presence of ulcers, calciﬁc
atheromas, rupture of intima or media and traction lesions
due to prelevation in arteries; signs of phlebitis, athero-
matosis, parietal abnormalities; and lesions of intima in
veins. Serologic testing for human immunodeﬁciency virus,
hepatitis B and C and syphilis was also done and vessels
were excluded in the case of positivity. One centimetre long
vessel samples were placed in HEPES-buffered Hanks’
balanced salt solution (HBSS-HEPES) and prior to cryopres-
ervation, dimethylsulphoxide (DMSO) was added to a ﬁnal
concentration of 15%. DMSO is the most commonly used
cell membrane-permeating freeze point-lowering agent for
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to 15% were shown to be safe for that purpose.21 In Gap27-
treated vessels, the peptide was added to the HBSS-HEPESe
DMSO solution at a ﬁnal concentration of 200 mM. Grafts
were cryopreserved at a rate of 1 C min1 in a 80 C
freezer and after 2 weeks stored for at least another 2
weeks in a liquid nitrogen container (196 C).
For vessel analysis and cell death studies, tissues were
thawed in a 37 C water bath and kept on ice before the
next steps. DMSO was then progressively washed out by
a stepwise reduction of the DMSO concentration in the
HBSS-HEPES solution. To that purpose, the blood vessels
remained for 4 min in HBSS-HEPES solution with 10%, 5%,
2.5% and 0% DMSO, respectively. In Gap27-treated vessels,
the peptide (200 mM) was present during DMSO washout.
As shown in Fig. 6(a), we also performed experiments to
verify the effect of Gap27 when included during cryopres-
ervation/thawing only or during DMSO washout only.
After DMSO washout, vessels were embedded in parafﬁn
and cut in 5 mm sections. Immunostaining for connexin
expression was performed and apoptosis was detected
through in situ TUNEL, using the In Situ Cell Death Detection
Kit (Roche, Vilvoorde, Belgium). Further details can be found
in ‘Supplementary materials’.Statistical analysis
All data are expressed as mean  standard error of the
mean (SEM). Statistical analysis between groups was per-
formed using the Friedman test with Dunn’s post-t-test.
Proportions were compared using Pearson’s chi-squared
test. Differences in cell death between control conditions of
both blood vessels were analysed by the unpaired Student’s
t-test. Correlations were assessed by Pearson’s correlation
tests. A value of P < 0.05 was considered as statistically
signiﬁcant. The symbol n represents the number of blood
vessels.
RESULTS
Connexin expression in human femoral arteries and
saphenous veins
Immunostainings demonstrated the presence of the major
vascular connexins, Cx37, Cx40 and Cx43 in the intimal and
medial layers of human cryopreserved blood vessels. Cx37
was mainly found in the intimal EC layer of saphenous veins,
while it was present in intimal EC and medial SMC layers in
femoral arteries (Fig. 2(a)e(d)). Cx40 was found in both
arteries and veins and was present in the intimal and medial
layers (Fig. 2(e)e(h)). Cx43 was most abundantly present
and was mainly located in the medial layer of femoral
arteries and in intimal and medial layers of saphenous veins
(Fig. 2(i)e(l)).Intimal-layer detachment after cryopreservation is more
important in femoral arteries than in saphenous veins
Morphological analysis of haematoxylineeosin-stained
blood-vessel sections showed that femoral arteries hada pronounced detachment of the intimal lining compared to
saphenous veins (Fig. 3(a)e(d)). Quantiﬁcation of the
number of blood vessels with an intact intimal layer, with
<50% intimal loss and with >50% loss allowed us to
construct a graph depicting the distribution pattern of loss
of intimal integrity (Fig. 3(c) and (d)). These data showed
a signiﬁcantly different distribution pattern between
femoral arteries and saphenous veins, with a clearly better
conserved intimal lining in the latter.When Gap27 (200 mM)
was included during cryopreservation, thawing and DMSO
washout, the number of vessels with >50% intimal loss was
decreased but this visible difference did not attain statistical
signiﬁcance (Fig. 3(c) and (d)). We veriﬁed whether intimal
loss was correlated with the time between vessel
procurement from the donor and the start of cryopreser-
vation but found no signiﬁcant correlation.Gap27 reduces apoptotic-cell death in cryopreserved
human blood vessels
In order to quantify cell death in cryopreserved/thawed
blood vessels, we performed TUNEL stainings to detect
apoptotic call death. As can be appreciated from Fig. 4(a)
and (c), non-treated blood vessels displayed clearly
discernible TUNEL positivity in the intimal and medial
layers. We veriﬁed whether the degree of TUNEL positivity
varied with the duration of the time interval between vessel
procurement and start of cryopreservation but found no
signiﬁcant correlation. Interestingly, we found that Gap27
(200 mM) visibly reduced TUNEL positivity counts when it
was present during cryopreservation, thawing and DMSO
washout. Average data of several such experiments are
given in Fig. 5. In femoral arteries, w27% of the ECs and
w5% of the SMCs were TUNEL positive under control
conditions. Gap27 signiﬁcantly reduced these cell death
counts by more than 1/3 in the intimal layer and by more
than 2/3 in the medial layer (Fig. 5(a) and (c)). In saphenous
veins, TUNEL positivity wasw14% in ECs andw6% in SMCs.
Gap27 signiﬁcantly reduced these counts by almost 1/2 in
ECs and by more than 1/2 in SMCs (Fig. 5(b) and (d)). Gap27
with a scrambled peptide sequence had no signiﬁcant
effects on cell death counts (Fig. 5). Thus, Gap27 more than
halved cell death in SMCs while cell death reduction was
less than half in ECs.
Cell death in control (without Gap27) was much more
prominent in ECs than in SMCs (ECs: 27% and 14% in
arteries and veins respectively vs. SMCs: 5% and 6%) and, as
a consequence, the fraction of cells rescued by Gap27 may
be more important in ECs as compared to SMCs. We
therefore calculated the protective effect of Gap27 relative
to the total number of cells (EC or SMC) as an alternative to
calculations relative to the number of dead cells. Table 1
summarises these two measures of Gap27 protection and
demonstrates that the cell mass rescued by Gap27 was
larger in ECs than in SMCs. Note that the numbers given in
Table 1 were calculated from the combined data of Figs. 5
and 6 and therefore differ slightly from the relative effect
size described above in relation to Fig. 5.
Figure 2. Connexin expression in human saphenous veins and femoral arteries. AeD. Representative example images illustrating Cx37
immunostainings (red) overlayed on nuclear DAPI stainings (blue) in endothelial cells in the intimal and smooth muscle cells in the medial
layer of femoral arteries (Artery) and saphenous veins (Vein). EeH. Example images illustrating Cx40 expression. IeL. Example images
illustrating Cx43 expression.
M. Bol et al. 385
Figure 4. Gap27 reduces apoptotic cell death in EC and SMC layers in cryopreserved human blood vessels. AeD. Example images of TUNEL
(AeB, green) and DAPI (CeD, blue) stained sections of femoral arteries under control and after Gap27 treatment. The number of TUNEL
positive cells was visibly reduced by Gap27 in ECs and SMCs from intimal and medial layers respectively.
50 µm50 µm
A
C
B
D
Media
Intima
Media
Intima
Control Gap27
0
2
4
6
8
10
intact intima
< 50 % intimal loss
> 50 % intimal loss
#
b
l
o
o
d
v
e
s
s
e
l
s
Control Gap27
0
2
4
6
8
10
> 50 % intimal loss
< 50 % intimal loss
intact intima
#
b
l
o
o
d
v
e
s
s
e
l
s
**
Arteries Veins
Figure 3. Intimal layer detachment in femoral arteries and saphenous veins. AeB. Example images illustrating an intact (A) and detached
intimal layer (B) in two different femoral arteries. CeD. Summary data illustrating intimal loss distribution patterns of femoral arteries (C)
and saphenous veins (D). The intimal layer was signiﬁcantly better conserved in saphenous veins than in femoral arteries (**P < 0.01).
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Figure 5. Gap27 reduces apoptotic cell death in cryopreserved human blood vessels e average data. Apoptotic cell death in ECs (A, B) and
SMCs (C, D) of femoral arteries (A, C) and saphenous veins (B, D). The number of TUNEL positive cells was signiﬁcantly reduced by Gap27 in
ECs and SMCs. Gap27 with a scrambled peptide sequence had no signiﬁcant effects on cell death counts. The numbers of vessels are
indicated in the bars. *P < 0.05.
M. Bol et al. 387Comparison of the control bars in panels A and B of Fig. 5
suggests that EC death is more prominent in arteries than in
veins; panels H and I of Fig. 6 (presented below) indicate
a similar difference. Table 2 summarises average results in
control conditions from the combined data sets of Figs. 5
and 6 with extra data from additional experiments and
shows that EC death was signiﬁcantly lower in veins as
compared to arteries.
In a next step, we determined in which phase Gap27
exerted most of its protective effects: during cryopreser-
vation/thawing or during DMSO washout. Thus, we inves-
tigated cell death with Gap27 being included either during
cryopreservation/thawing or during DMSO washout
(Fig. 6(a)). We found that inclusion of Gap27 during DMSO
washout only, slightly (but non-signiﬁcantly) reduced cell
death in ECs and SMCs while inclusion during cryopreser-
vation/thawing only always gave larger and statistically
signiﬁcant protective effects in both femoral artery and
saphenous vein. Fig. 6(b)e(g) illustrates example images of
TUNEL and 40,6-diamino-2-phenylindole (DAPI) stainings
while average data are given in Fig. 6(h)e(k).Table 1. Protective effect of Gap27 on cell death in ECs and SMCs.
Protection relative to total number of dead cells (%)
Arteries Veins
EC 32  8 (n ¼ 11) 51  8 (n ¼ 13)
SMC 73  7 (n ¼ 11) 71  6 (n ¼ 13)
Average values express inhibitory effect based on Gap27 treatment da
cryopreservation/thawing).DISCUSSION
This study demonstrates that inhibition of connexin chan-
nels (gap junctions and hemichannels) with the connexin
mimetic peptide Gap27 that targets Cx37 and Cx43 signiﬁ-
cantly reduces cell death of SMCs and ECs in cryopreserved
and subsequently thawed human femoral arteries and
saphenous veins. Gap27 had slight but non-signiﬁcant
effects when it was present during DMSO washout only and
most of its protective effect appeared to be related to its
presence during cryopreservation/thawing.
Cryopreserved vessels are being increasingly employed in
vascular reconstruction procedures.22 The considerable cell
death provoked by cryopreservation is a major factor
leading to the post-transplantation failure of vascular allo-
grafts.5 In the present study, apoptotic cell death was more
pronounced in the intimal layer than in the medial layer.
Apoptosis in the ECs of vascular grafts has been extensively
addressed in previous reports.5,23,24 and the inﬂuence of
alternative procedures for prelevation, cryopreservation
and thawing have been scrutinised.4,5 When compared to
the application of a more gradual, automated thawingProtection relative to total number of cells (%)
Arteries Veins
11  4 (n ¼ 11) 12  4 (n ¼ 13)
6  3 (n ¼ 11) 6  2 (n ¼ 13)
ta of Figs. 5 and 6 (Fig. 6 condition with Gap27 present during
Figure 6. Gap27 exerts most of its protective effect when added during cryopreservation/thawing. A. Overview of the different treatment
protocols used. ‘Cryopreservation’ refers to cryopreservation/thawing and ‘washout’ to DMSO washout. BeD. Example images of TUNEL
stainings (green) in a saphenous vein. EeG. Corresponding example images of nuclear DAPI staining (blue) in the same preparation.
Treatment was as indicated in the horizontal bars above each image (A). HeK. Average data of experiments as illustrated in AeG. Inclusion
of Gap27 during DMSO washout-only, slightly (but non-signiﬁcantly) reduced cell death in ECs and SMCs while inclusion during cryo-
preservation/thawing-only always gave larger and statistically signiﬁcant protective effects in both femoral artery and saphenous vein
preparations. Numbers of vessels are indicated in the bars. *P < 0.05.
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Gap27 appears to be stronger. It remains to be determined
whether the combination of these treatments, that is,
automated slow thawing plus inclusion of Gap27, yields an
additive effect. Automated thawing is, however, not avail-
able as a standard procedure in all hospitals. Compromisedendothelial preservation can lead to vasospasms, occlusive
intimal hyperplasia and accelerated atherosclerosis.25 Other
reports have indicated the occurrence of apoptosis and
SMC loss in the tunica media23,26 which, together with
intimal proliferative lesions, can lead to chronic rejection of
the arterial allograft.26
Table 2. Vascular cell death in femoral arteries and saphenous
veins.
Arteries Veins
EC 30  5% (n ¼ 15) 17  3% a (n ¼ 17)
SMC 7  3% (n ¼ 15) 7  2% (n ¼ 17)
Average values based on control condition data of Figs. 5 and 6
and additional experiments.
a Signiﬁcantly below value for arteries with P < 0.05.
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tion pathway, connecting the cytoplasm of adjacent cells.
They have a central role in vascular physiology, helping in
coordinating the contraction of SMCs,27 communicating
electrical and Ca2þ signals in upstream direction via the
endothelium28 and contributing to the ﬁne-tuning of ECe
SMC communication via myo-endothelial gap junctions.
Additionally, gap junctions allow the passage of cell death
messenger signals, thereby potentially contributing to the
propagation of cell death known as bystander cell death.7
Work of our lab has recently demonstrated that the physio-
logical messenger IP3 can turn into a crucial cell death
messenger under pro-apoptotic conditions.10 While gap
junctions may cause propagated bystander cell death,
unapposed hemichannels may cause cell death by uncon-
trolled opening, thereby contributing to the entry and escape
from the cell of ions and small molecules beloww1.5 kDa.7
Work from our lab has demonstrated that this effect may
additionally contribute to the propagation of cell death.13
We here demonstrate the presence of vascular connexins
Cx37, Cx40 and Cx43 in human femoral arteries and
saphenous veins. Previous studies have reported that con-
nexin expression varies with vessel type, species and even
vessel diameter.9
These studies indicated Cx37 expression primarily in the
intima, Cx40 in both intima and media and a prominent
expression of Cx43 typically in the medial SMC layer. Our
results grossly support this pattern with the exception that
Cx37 was also found (although not prominently) in the media
of human arteries and Cx43 in the intima of human veins
(again much less prominent than in the media). We used
Gap27 thatmimics the second extracellular loop of both Cx37
and Cx43, to inhibit gap junctions and hemichannels.13,15,16
Our results show a clear decrease of cell death in the
intimal and medial layers of arteries and veins treated with
Gap27. The smaller effect of Gap27 on EC death of arteries
(Fig. 5(a) and Table 1) may be related to a lower Cx43
expression in this layer. Interestingly, the gap junction and
hemichannel inhibitors carbenoxolone and Gap26 were
previously reported to reduce neointimal formation and this
led to a reduced SMC deterioration and decreased risk for
atherosclerosis and other complications.29 In addition to
this, it is important to realise that Gap27-reduced SMC
death may be beneﬁcial for ECs because the two cells are
coupled via myo-endothelial gap junctions (Fig. 1) that may
pass cell-death messengers from SMCs (the largest vascular-
cell population) to ECs. Conversely, a reduction by Gap27 of
EC death may be beneﬁcial at the functional level after
transplantation given the important role of these junctionsin endothelial control over SMC function.28 Previous work
has demonstrated that cryopreservation of arterial speci-
mens in low calcium solutions is associated with (unex-
pected) increased cell death.4 Low extracellular calcium
conditions are known to trigger hemichannel opening,30
and it is tempting to speculate that this is one of the causes
leading to increased vascular cell death. Thus, combining
low extracellular calcium and Gap27 would be an inter-
esting option to be explored in follow-up work.
Gap27 exerted most of its protective effects during
cryopreservation/thawing, while it was far less effective
when only present during DMSO washout after thawing.
Earlier reports have indicated that rapid thawing increases
the fragility of the arterial vessel wall and leads to spon-
taneous macro- and microfractures in the vessel wall due to
thermal stress created by temporal and spatial temperature
gradients.4,31 It was earlier reported that the procedure of
vascular cryopreservation used at most vascular banks
provokes a certain loss of the endothelium, which is one of
the main factors leading to graft failure.5 Our work
demonstrates that detachment of the endothelial layer was
more often observed in arteries than in veins; also, EC death
was more pronounced in arteries than in veins. Previous
reports have demonstrated that slow thawing is better
suited for arterial grafts;32 thus, the prominent detachment
of the endothelial layer in arteries may be related to the
less than optimal thawing procedure used in our experi-
ments. However, since slow thawing is not widely available
in most hospitals, venous grafts, with a better preserved
endothelium and therefore better antithrombotic potential,
should be recommended for patients with severe vascular
disease and with a higher risk for thrombosis.
In conclusion, inhibition of the vascular connexins Cx37
and Cx43 with Gap27 peptide signiﬁcantly protects human
blood vessels against cell death that occurs in relation to the
cryopreservation/thawing procedure. Gap27 contains
a sequence identical to an extracellular-facing domain of
Cx37 and Cx43 and will thus not act immunogenically when
some residual peptide would be left over after thorough
washing. Further studies including clinical application of the
peptides will be needed to determine whether the protective
potential of this treatment translates into a clinically better
outcome after graft vessel transplantation in patients.
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